Earnings Ahead

AGIO - Agios Pharmaceuticals

28.13 0.66 2.4

Agios Pharmaceuticals

Agios Pharmaceuticals

About

Profile


Headquarters

Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AGIO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Agios Pharmaceuticals GAAP EPS of -$6.33 misses by $0.07, revenue of $26.82M misses by $0.9M
  • Agios Pharmaceuticals Q4 2023 Earnings Preview
  • AIM stock dips amid mixed results for post-COVID fatigue therapy
  • CRISPR, bluebird stocks slide as Agios rallies on thalassemia study
  • Agios stock rallies after mitapivat meets key goal in thalassemia trial
  • Agios Pharmaceuticals GAAP EPS of -$1.64 beats by $0.06, revenue of $7.4M misses by $0.13M
  • Agios Pharmaceuticals Q3 2023 Earnings Preview
  • Agios Pharmaceuticals GAAP EPS of -$1.51 beats by $0.05, revenue of $6.7M beats by $0.24M
  • Agios Pharmaceuticals Q2 Earnings Preview
  • Agios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37M
  • Agios Pharmaceuticals Q1 2023 Earnings Preview
  • Agios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35M
  • Agios rare blood disorder drug Pyrukynd sustains benefits in patients in long term data
  • Agios Pharmaceuticals upgraded to neutral at Goldman Sachs on Pyrukynd outlook
  • Agios granted EU approval for Pyrukynd in pyruvate kinase deficiency
  • Agios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72M
  • Agios sells its rights to royalties on U.S. sales of cancer drug Tibsovo for $131.8M
  • Agios appoints Cecilia Jones as finance chief
  • Agios Pyrukynd for rare blood disorder gets EMA panel backing for approval in EU
  • Agios CFO Jonathan Biller to quit

Earnings History

Date EPS / Forecast Revenue / Forecast
February 24, 2022 -1.81 / -1.66 - / 410K
November 3, 2021 -1.48 / -1.57 - / 2.55M
July 29, 2021 -1.41 / -1.33 - / -
April 29, 2021 26.95 / -1.29 - / -
February 25, 2021 -1.41 / -1.31 44.05M / 39.86M Beat!
November 5, 2020 -1.43 / -1.36 34.71M / 38.12M
July 30, 2020 -1.31 / -1.36 37.35M / 37.14M Beat!
April 30, 2020 -0.59 / -1.67 87.1M / 31.12M Beat!
February 13, 2020 -1.6 / -1.7 35.44M / 33.72M Beat!
October 31, 2019 -1.81 / -1.8 26.02M / 33.13M
August 1, 2019 -1.87 / -1.7 26.22M / 27.01M
May 2, 2019 -1.59 / -1.75 30.23M / 22.69M Beat!
February 14, 2019 -1.58 / -1.67 30.01M / 18.83M Beat!
November 1, 2018 -1.63 / -1.62 15.2M / 19.12M
August 2, 2018 -1.19 / -1.57 40.41M / 9.95M Beat!
May 4, 2018 -1.63 / -1.63 8.76M / 10.84M
February 14, 2018 - / -1.66 - / 13.34M
November 1, 2017 -1.59 / -1.79 11.36M / 9.77M Beat!
August 8, 2017 -1.78 / -1.73 11.35M / 9.62M Beat!
May 4, 2017 -1.56 / -1.54 10.51M / - Beat!
February 16, 2017 -1.34 / -1.48 22.65M / 16.03M Beat!
November 3, 2016 -1.63 / -1.45 8.99M / 7.19M Beat!
Date Price Open High Low Vol Change
May 17 34.34 35
35.01
34.07
655K -1.89%
May 16 35 35
35.2
34.83
360K -0.51%
May 15 35.18 34.49
35.32
34.35
525K 3.05%
May 14 34.14 33.55
34.19
33.2
518K 1.79%
May 13 33.54 33.15
33.66
32.77
460K 1.64%
 
May 10 33 32.94
33.09
32.46
506K 0.24%
May 9 32.92 32.76
33.58
32.28
868K 1.42%
May 8 32.46 32.42
32.71
31.84
773K -1.04%
May 7 32.8 33.47
33.51
32.52
708K -1.26%
May 6 33.22 33.47
35.11
33.21
684K -3.82%
May 3 34.54 34.9
35.4
33.69
711K -0.12%
May 2 34.58 33.59
35.36
33.16
694K 2.73%
May 1 33.66 32.3
34.58
32.3
857K 3.57%
Apr 30 32.5 32.63
33.3
31.77
661K -0.79%
Apr 29 32.76 31.5
33.22
31.5
735K 4.03%
Apr 26 31.49 31.7
32.01
31.31
417K -0.57%
Apr 25 31.67 31.22
32.25
31.22
722K 0%
Apr 24 31.67 32.08
32.26
31.32
544K -0.44%
Apr 23 31.81 30.4
33.02
30.4
1.2M 5.30%
Apr 22 30.21 29.66
30.89
29.5
862K 2.30%
Apr 19 29.53 29.27
30.28
28.71
747K 0.34%
Apr 18 29.43 29.1
29.9
29.03
549K 1.38%
Apr 17 29.03 28.93
29.34
28.89
485K 0.80%
Apr 16 28.8 29.07
29.58
28.74
471K -1.57%
Apr 15 29.26 29.78
29.8
28.73
618K -0.85%
Apr 12 29.51 30.5
30.69
28.71
754K -3.66%
Apr 11 30.63 30.4
31.01
29.9
803K 2.30%
Apr 10 29.94 29.23
30.26
29.05
739K 0.77%
Apr 9 29.71 27.84
29.85
27.81
959K 7.26%
Apr 8 27.7 27.56
28.39
27.14
735K 0.54%
Apr 5 27.55 27.79
28.25
27.45
566K -1.33%
Apr 4 27.92 28.81
28.86
27.72
391K -1.93%
Apr 3 28.47 28.56
28.78
27.99
542K -0.7%
Apr 2 28.67 28.38
28.99
27.89
590K -0.66%
Apr 1 28.86 29.28
29.37
28.66
417K -1.3%
Mar 28 29.24 29.19
29.41
28.82
435K 0.41%
Mar 27 29.12 29.24
29.45
28.57
666K 0.21%
Mar 26 29.06 30.07
30.23
28.87
555K -2.09%
Mar 25 29.68 29.81
30.21
29.51
414K -0.67%
Mar 22 29.88 30.4
30.66
29.83
442K -1.19%
Mar 21 30.24 30.24
31.48
30.16
539K 0.03%
Mar 20 30.23 29.93
30.78
29.74
611K 0.47%
Mar 19 30.09 29.35
30.39
29.28
545K 2.73%
Mar 18 29.29 29.88
30
28.94
550K -2.17%
Mar 15 29.94 29.4
30.33
29.4
1.2M 1.63%
Mar 14 29.46 29.82
30
29.02
539K -1.8%
Mar 13 30 30.31
31.04
29.82
518K -0.96%
Mar 12 30.29 30.74
30.86
30.02
518K -1.66%
Mar 11 30.8 31.44
31.77
30.68
411K -1.57%
Mar 8 31.29 31.81
32.04
30.9
461K -0.26%
Mar 7 31.37 31.99
32.6
31.27
581K -1.32%
Mar 6 31.79 31.4
32.1
31.14
1.6M 1.34%
Mar 5 31.37 31.96
32.26
31.25
459K -2.49%
Mar 4 32.17 32.43
32.63
31.28
685K -0.31%
Mar 1 32.27 32.35
33.04
32.09
842K -0.15%
Feb 29 32.32 34.25
34.25
32.24
858K -4.01%
Feb 28 33.67 34.55
35.48
33.48
979K -3.27%
Feb 27 34.81 33
35.5
32.9
1.6M 5.90%
Feb 26 32.87 32.86
33.75
32.23
957K -0.36%
Feb 23 32.99 29.87
33.91
29.87
2.6M 0%